GCPL Q1 FY27: consol PAT +11.5% YoY, standalone soft at +2.3% as India margins compress

Godrej Consumer Products posted consolidated revenue of ₹4,225.47 Cr for Q1 FY27 (quarter ended June 30, 2026), up 18.3% YoY on a like-for-like restated basis (+8.3% QoQ), with PAT of ₹504.52 Cr, up 11.5% YoY (+11.7% QoQ) and basic EPS of ₹4.93 versus ₹4.42 a year ago. This lands roughly in line with both management's own high-teens revenue guidance for the quarter (flagged July 3) and the Street's pre-result consensus of ~17% YoY consolidated revenue growth — not a beat, but on-plan. PAT growth trailing revenue growth reflects the margin compression management explicitly guided for on May 6: consolidated NPM eased to 12.0% from 12.7% a year ago, and OPM to 19.0% from 19.4%, consistent with the flagged 7-9% cost inflation being only partly offset so far by the 4-7% price hikes taken across categories.

The growth was unevenly sourced. Africa (including Strength of Nature) was the standout, with segment revenue up 47.1% YoY to ₹1,006.13 Cr and segment profit up 40.1% to ₹102.69 Cr — well ahead of management's guided "sustained double-digit growth" for the region. Indonesia grew a healthy 15.3% YoY to ₹486.91 Cr (profit +10.6%). India, the largest segment at roughly 60% of consolidated revenue, grew a comparatively modest 11.4% YoY to ₹2,557.41 Cr, with segment margin compressing to 20.7% from 23.2% a year ago — the clearest evidence of where the cost-inflation squeeze is biting hardest. This domestic softness shows up starkly in the standalone (largely India) numbers: standalone PAT grew just 2.3% YoY to ₹362.72 Cr on 11.4% revenue growth, with NPM down more sharply to 14.3% from 15.6%. Readers tracking the standalone print separately should note it is a materially weaker read than the consolidated headline — international operations, not the India "mothership," are doing the heavy lifting on profit growth this quarter.

The stock went into the print at ₹1,048, down 3.6% over the past month of trading.

For context: this is the highest quarterly PAT in the last 6 quarters on our records; revenue is at a 6-quarter high.

Exception items were a modest drag in both periods and roughly comparable in size, so they don't change the underlying picture much: consolidated exceptional charges of ₹15.56 Cr this quarter (Strength of Nature US litigation costs ₹7.96 Cr, India/Indonesia/Africa restructuring ₹9.10 Cr, partly offset by a ₹5.57 Cr labour-code gratuity/leave credit and a ₹4.07 Cr Muuchstac fair-value charge) compare with a ₹19.54 Cr charge a year ago; stripping both out, PBT before exceptionals grew 9.3% YoY (₹692.11 Cr vs ₹633.24 Cr), and adjusted PAT growth works out to roughly 10.5% — close to the 11.5% reported figure, confirming the one-offs aren't distorting the story either way. The Board also declared an interim dividend of ₹5/share (record date August 13, 2026), matching the dividend signal flagged ahead of this print. No separate management press release was available alongside this filing — only the board-outcome letter and financial statements.